LifeMD, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
LFMD$2.10-11.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| ASSETS | ||
| Current Assets | ||
| Cash | $34,478,137 | $36,786,318 |
| Accounts receivable | 9,855,117 | 9,305,277 |
| Product deposit | 331,525 | 320,217 |
| Inventory, net | 3,177,136 | 2,773,576 |
| Other current assets | 3,855,131 | 2,646,077 |
| Total Current Assets | 51,697,046 | 51,831,465 |
| Non-current Assets | ||
| Equipment, net | 2,260,437 | 2,444,717 |
| Right of use assets, net | 5,055,090 | 5,267,857 |
| Capitalized software, net | 10,881,678 | 10,604,946 |
| Intangible assets, net | 230,417 | 262,334 |
| Total Non-current Assets | 18,427,622 | 18,579,854 |
| Total Assets | $70,124,668 | $70,411,319 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current Liabilities | ||
| Accounts payable | $21,653,122 | $14,149,154 |
| Accrued expenses | 15,244,963 | 15,974,016 |
| Current operating lease liabilities | 670,825 | 642,422 |
| Deferred revenue | 12,016,840 | 10,807,773 |
| Total Current Liabilities | 49,585,750 | 41,573,365 |
| Long-term Liabilities | ||
| Noncurrent operating lease liabilities | 5,502,072 | 5,681,374 |
| Total Liabilities | 55,087,822 | 47,254,739 |
| Commitments and contingencies (Note 12) | - | - |
| Stockholders’ Equity | ||
| Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $35.8 million as of March 31, 2026 and December 31, 2025 | 140 | 140 |
| Common Stock, $0.01 par value; 100,000,000 shares authorized, 47,632,707 and 46,760,016 shares issued, 47,529,667 and 46,656,976 outstanding as of March 31, 2026 and December 31, 2025, respectively | 476,327 | 467,600 |
| Additional paid-in capital | 252,976,314 | 251,455,616 |
| Accumulated deficit | (238,252,234) | (228,603,075) |
| Treasury stock, 103,040, at cost, as of March 31, 2026 and December 31, 2025 | (163,701) | (163,701) |
| Total Stockholders’ Equity | 15,036,846 | 23,156,580 |
| Total Liabilities and Stockholders’ Equity | $70,124,668 | $70,411,319 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.